Processes for preparing calanolide a and intermediates thereof
申请人:——
公开号:US20040106808A1
公开(公告)日:2004-06-03
The present invention provides a production method of Calanolide A according to the following method
1
wherein each symbol is as defined in the specification, as a more convenient and industrially practical method for the synthesis of Calanolide A from an easily available starting material.
PROCESSES FOR PREPARING CALANOLIDE A AND INTERMEDIATES THEREOF
申请人:Kuraray Co., Ltd.
公开号:EP1352907A1
公开(公告)日:2003-10-15
The present invention provides a production method of Calanolide A according to the following method
Scheme 1
wherein each symbol is as defined in the specification, as a more convenient and industrially practical method for the synthesis of Calanolide A from an easily available starting material.
本发明根据以下方法提供了一种 Calanolide A 的生产方法
方案 1
其中各符号如说明书中所定义,是一种从容易获得的起始原料合成Calanolide A的更方便和工业实用的方法。
POLYCYCLIC DERIVATIVES TARGETING RAL GTPASES AND THEIR THERAPEUTICAL APPLICATIONS
申请人:NANTBIO, INC.
公开号:US20180170942A1
公开(公告)日:2018-06-21
Contemplated compounds, compositions and methods are directed to Ral GTPase inhibitors with improved activity.
[EN] POLYCYCLIC DERIVATIVES TARGETING RAL GTPASES AND THEIR THERAPEUTICAL APPLICATIONS<br/>[FR] DÉRIVÉS POLYCYCLIQUES CIBLANT DES GTPASES RAL ET LEURS APPLICATIONS THÉRAPEUTIQUES
申请人:NANTBIOSCIENCE INC
公开号:WO2016205460A1
公开(公告)日:2016-12-22
Contemplated compounds, compositions and methods are directed to Ral GTPase inhibitors with improved activity.